A combination, comprising an endothelin receptor antagonist, or a pharmaceutically acceptable salt thereof, and an EGFR TKI, or a pharmaceutically acceptable salt thereof is described.
申请公布号
CA2501959(A1)
申请公布日期
2004.04.29
申请号
CA20032501959
申请日期
2003.10.07
申请人
ASTRAZENECA AB
发明人
CURWEN, JON OWEN;BOYLE, FRANCIS THOMAS;GALLAGHER, NEIL JAMES;TAYLOR, SIAN TOMIKO;TONGE, DAVID WILLIAM;JOHNSTONE, DONNA;HUGHES, ANDREW MARK;HANCOX, URSULA JOY
